1
Home
Companies

Acumen Pharmaceuticals

#9418

Rank

$81.77M

Marketcap

US United States

Country

Acumen Pharmaceuticals
Leadership team

Mr. Daniel J. O'Connell M.B.A. (CEO, Pres & Director)

Mr. Matt Zuga (CFO, Chief Bus. Officer & Corp. Sec.)

Dr. Eric Siemers M.D. (Chief Medical Officer)

Products/ Services
Biotechnology, Health Diagnostics, Therapeutics
Headquarters
Carmel, Indiana, United States
Established
1996
Company Registration
SEC CIK number: 0001576885
Net Income
20M - 100M
Traded as
ABOS
Social Media
URL
https://acumenpharm.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
History

Acumen was founded in 2001 by Jacqueline Novogratz, with help of seed capital from the Rockefeller Foundation, Cisco Systems Foundations and three individual philanthropists. Acumen uses a business mechanism to fight poverty, investing in for-profit businesses that treat the poor as customers.

Mission
Our mission is to develop innovative and effective treatments that improve the lives of individuals and their families suffering from respiratory, cardiovascular, and metabolic diseases.
Vision
Our vision is to be a global leader in biopharmaceuticals, developing new therapies and treatments to improve the lives of people worldwide.
Key Team

Mr. Russell Barton M.S. (Chief Operating Officer)

Ms. Janice Hitchcock (VP & Head of Regulatory Affairs)

Mr. Derek M. Meisner Esq., J.D. (Chief Legal Officer)

Ms. Liean Schenck M.S. (VP & Head of CMC)

Ms. Robyn Moxon M.A. (Mang. of Corp. & Clinical Communications)

Ms. Julie Bockenstette (Exec. VP & Head of HR)

Ms. Siew Tin Gan M.S. (Assistant VP & Head of Clinical Operations)

Recognition and Awards
Acumen Pharmaceuticals has been recognized in numerous occasions as a leader in biopharmaceuticals and innovative drug development. It has been named one of the top 100 fastest growing companies in the US for the past three consecutive years and has received numerous awards for its breakthrough therapies and new treatments for diseases.
References

https://en.wikipedia.org/wiki/Acumen_(organization)

https://in.investing.com/equities/acumen-pharmaceuticals

https://finance.yahoo.com/quote/ABOS/profile?p=ABOS

https://www.crunchbase.com/organization/acumen-pharmaceuticals

https://companiesmarketcap.com/

https://acumenpharm.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Acumen Pharmaceuticals
Leadership team

Mr. Daniel J. O'Connell M.B.A. (CEO, Pres & Director)

Mr. Matt Zuga (CFO, Chief Bus. Officer & Corp. Sec.)

Dr. Eric Siemers M.D. (Chief Medical Officer)

Products/ Services
Biotechnology, Health Diagnostics, Therapeutics
Headquarters
Carmel, Indiana, United States
Established
1996
Company Registration
SEC CIK number: 0001576885
Net Income
20M - 100M
Traded as
ABOS
Social Media
URL
https://acumenpharm.com